|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.100 USD | -1.41% |
|
-4.55% | -39.31% |
| 08-24 | Grace Therapeutics Files for Resale of Up to 4.8 Million Shares | MT |
| 08-13 | Grace Therapeutics, Inc. Reports Impairment charges for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 61.41M 44.18M 38.11M 35.84M 32.65M 4.19B 61.74M 424M 165M 2.13B 166M 162M 7.07B | P/E 2027 * |
-1.75x | P/E 2028 * | -4.56x |
|---|---|---|---|---|---|
| Enterprise Value | 61.41M 44.18M 38.11M 35.84M 32.65M 4.19B 61.74M 424M 165M 2.13B 166M 162M 7.07B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 8.98x |
| Free-Float |
81.8% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -1.41% | ||
| 1 week | -4.55% | ||
| Current month | -1.41% | ||
| 1 month | +0.96% | ||
| 3 months | -21.93% | ||
| 6 months | -51.05% | ||
| Current year | -39.31% |
| 1 week | 2.07 |  | 2.18 |
| 1 month | 2.02 | | 2.25 |
| Current year | 1.79 | | 5.18 |
| 1 year | 1.79 | | 5.18 |
| 3 years | 1.72 | | 5.18 |
| 5 years | 1.72 | | 15.36 |
| 10 years | 1.72 | | 161.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 54 | 03/04/2023 |
| Director of Finance/CFO | 55 | 04/01/2024 | |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 65 | 07/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Prashant Kohli
BRD | Director/Board Member | 54 | 03/04/2023 |
A. Davis
BRD | Director/Board Member | 59 | 09/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | Opaleye Management, Inc.
| Buy | Company | 11,608 | 0.0713% | |
| 12/01/26 | Option | Chairman | 10,000 | 0.0646% | ||
| 12/01/26 | Option | Director | 10,000 | 0.0646% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.41% | -4.55% | -30.69% | +0.01% | 44.18M | |
| -0.25% | -4.10% | +38.38% | +92.61% | 68.21B | |
| +0.77% | -0.51% | +47.36% | +88.04% | 64.25B | |
| -0.25% | -1.92% | -10.72% | +436.70% | 26.54B | |
| +0.33% | -10.61% | +1.95% | -16.27% | 25.61B | |
| +0.54% | -2.23% | +30.87% | -19.04% | 19.88B | |
| -6.09% | -12.08% | +226.11% | +375.00% | 17.13B | |
| +0.20% | -5.67% | -1.52% | +532.32% | 14.93B | |
| +4.12% | +0.30% | +52.03% | +150.18% | 14.1B | |
| -0.24% | +5.18% | +23.04% | +190.97% | 12.45B | |
| Average | -0.22% | -3.99% | +37.68% | +183.05% | 26.31B | |
| Weighted average by Cap. | -0.00% | -3.22% | +41.46% | +158.22% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 6.84M 4.92M 4.25M 3.99M 3.64M 467M 6.88M 47.21M 18.37M 238M 18.48M 18.08M 788M |
| Net income | -34.73M -24.98M -21.55M -20.27M -18.47M -2.37B -34.92M -240M -93.28M -1.21B -93.8M -91.77M -4B | -16.92M -12.17M -10.5M -9.87M -9M -1.15B -17.01M -117M -45.44M -588M -45.69M -44.7M -1.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$2.100 | -1.41% | 78,967 |
| 31/08/26 | US$2.130 | +0.47% | 117,306 |
| 28/08/26 | US$2.120 | -1.85% | 66,108 |
| 27/08/26 | US$2.160 | +0.47% | 82,267 |
| 26/08/26 | US$2.150 | -2.27% | 22,210 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GRCE Stock
Select your edition
All financial news and data tailored to specific country editions
